BioLife Solutions (BLFS) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $27.98 -0.89%
Revenue Growth %: +8.2%
Financial Fact:
Gross profit: 1.21M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: +8.2%
Financial Fact:
Gross profit: 1.21M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of $0.00, $0.07 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $31.2 million versus the consensus estimate of $27.55 million.
GUIDANCE:
BioLife Solutions sees FY2021 revenue of $108-117 million, versus the consensus of $110 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- JPMorgan cuts 2026 box office forecast on slow third quarter
- Ionis Pharmaceuticals (IONS) reaffirms guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
